⌘K

Login Start Free

Home/Filings/4/0001140361-12-031210

4//SEC Filing

Hwang Si Moon 4

Accession 0001140361-12-031210

CIK 0001228627other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:16 PM ET

Size

8.0 KB

Accession

0001140361-12-031210

Insider Transaction Report

Form 4

Period: 2012-06-18

REXAHN PHARMACEUTICALS, INC.RNN

Director

Transactions

Award
Stock Options (right-to-buy)
2012-06-18+20,000→ 20,000 total
Exercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)

Holdings

Common Stock
(indirect: By daughter)
7,000
Common Stock
(indirect: By Son)
7,000
Common Stock
341,198
Common Stock
(indirect: By daughter)
7,000

Footnotes (1)

[F1]These options vest and become exercisable in full on June 18, 2013.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeother

Related Parties

1

filerCIK 0001552942

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 4:16 PM ET
Size: 8.0 KB

View on SEC.gov